|
GARS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.64060029187397E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.58599999997311E-06 |
| Normal-vs-Stage2 |
2.146200E-02 |
| Normal-vs-Stage3 |
1.521800E-03 |
| Normal-vs-Stage4 |
2.035900E-02 |
| Stage1-vs-Stage2 |
3.885800E-01 |
| Stage1-vs-Stage3 |
6.004200E-02 |
| Stage1-vs-Stage4 |
1.270570E-01 |
| Stage2-vs-Stage3 |
3.233400E-01 |
| Stage2-vs-Stage4 |
2.666000E-01 |
| Stage3-vs-Stage4 |
8.334600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.65360000137227E-08 |
| Normal-vs-AfricanAmerican |
2.352700E-04 |
| Normal-vs-Asian |
1.371560E-01 |
| Caucasian-vs-AfricanAmerican |
6.805800E-01 |
| Caucasian-vs-Asian |
3.564600E-01 |
| AfricanAmerican-vs-Asian |
1.920960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.20109999957441E-07 |
| Normal-vs-Female |
1.23329999546229E-08 |
| Male-vs-Female |
1.564880E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.721520E-03 |
| Normal-vs-Extreme_Weight |
4.44990000000312E-05 |
| Normal-vs-Obese |
3.58089999999978E-05 |
| Normal-vs-Extreme_Obese |
5.200200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.469600E-01 |
| Normal_Weight-vs-Obese |
9.292000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.173400E-01 |
| Extreme_Weight-vs-Obese |
1.536190E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.548400E-01 |
| Obese-vs-Extreme_Obese |
1.504770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.936400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.71579999985738E-07 |
| Normal-vs-Age(61-80Yrs) |
1.34200000001528E-06 |
| Normal-vs-Age(81-100Yrs) |
6.016100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.758500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.476400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.784300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.763800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.167400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.830200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.26959999957599E-07 |
| Normal-VS-Type2 PRCC |
8.13410000000125E-05 |
| Normal-VS-KIRP CIMP |
3.643900E-04 |
| Normal-VS-Unclassified PRCC |
2.980800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.671600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.296420E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.675800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.78099999993098E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
4.090000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.238680E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.904400E-03 |
| Normal-vs-N1 |
1.612090E-04 |
| Normal-vs-N2 |
1.922180E-01 |
| N0-vs-N1 |
5.836800E-03 |
| N0-vs-N2 |
1.576640E-01 |
| N1-vs-N2 |
9.874800E-01 |
|
|
